1. Home
  2. Analysis
  3. Gabapentin
  4. Apremilast

Gabapentin and Apremilast drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 46 people who take Gabapentin and Apremilast. Common interactions include fatigue among females, and bradycardia among males.

The phase IV clinical study analyzes what interactions people who take Gabapentin and Apremilast have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2023

46 people who take Gabapentin and Apremilast together, and have interactions are studied.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is used in neuralgia. Currently, eHealthMe is studying from 301,958 Gabapentin users.

What is Apremilast?

Apremilast has active ingredients of apremilast. Currently, eHealthMe is studying from 3,235 Apremilast users.

Number of Gabapentin and Apremilast reports submitted per year:

Gabapentin and Apremilast drug interactions.

Common Gabapentin and Apremilast drug interactions by gender *:

female:

  1. Fatigue
  2. Haematuria
  3. Hot flush
  4. Influenza
  5. Influenza like illness
  6. Injection site bruising
  7. Injection site irritation
  8. Injection site nodule
  9. Injection site pruritus
  10. Injection site urticaria

male:

  1. Bradycardia
  2. Cytokine storm
  3. Pneumonia
  4. Retroperitoneal haematoma
  5. Septic shock
  6. Shock haemorrhagic
  7. Swelling
  8. Blood glucose increased
  9. Cardiac arrest
  10. Cardiac failure congestive

Common Gabapentin and Apremilast drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia
  2. Depression
  3. Hot flush
  4. Keratosis pilaris
  5. Nausea
  6. Night sweats
  7. Psoriasis
  8. Tooth disorder
  9. Tooth infection
  10. Vomiting

40-49:

  1. Back pain
  2. Drug ineffective
  3. Drug intolerance
  4. Facial pain
  5. Fatigue
  6. Haematuria
  7. Headache
  8. Influenza
  9. Injection site bruising
  10. Injection site irritation

50-59:

  1. Bradycardia
  2. Cytokine storm
  3. Disseminated intravascular coagulation
  4. Haemoglobin decreased
  5. Hyperglycaemia
  6. Hyperkalaemia
  7. Hypotension
  8. Iron deficiency
  9. Lactic acidosis
  10. Liver injury

60+:

  1. Diarrhoea
  2. Nausea
  3. Guillain-barre syndrome
  4. Injection site nodule
  5. Irritable bowel syndrome
  6. Musculoskeletal stiffness
  7. Palpitations
  8. Psoriasis
  9. Psoriatic arthropathy
  10. Road traffic accident

Common conditions people have *:

  1. Psoriasis (immune-mediated disease that affects the skin): 19 people, 41.30%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 23.91%
  3. Urination - Excessive Volume: 4 people, 8.70%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.70%
  5. Pain: 4 people, 8.70%
  6. High Blood Pressure: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Apremilast?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Gabapentin drug interactions:

Browse interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Apremilast drug interactions:

Browse interactions between Apremilast and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and apremilast (the active ingredients of Gabapentin and Apremilast, respectively), and Gabapentin and Apremilast (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gabapentin and Apremilast.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.